Pde6a Linked Retinitis Pigmentosa clinical trials

Explore recruiting pde6a linked retinitis pigmentosa clinical trials.

Also recruiting in Europe

Pde6a Linked Retinitis Pigmentosa trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PIGMENT – PDE6A gene therapy for retinitis pigmentosa

Germany

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Pde6a Linked Retinitis Pigmentosa trials by city

Pde6a Linked Retinitis Pigmentosa in Toronto Pde6a Linked Retinitis Pigmentosa in Vancouver Pde6a Linked Retinitis Pigmentosa in Montreal Pde6a Linked Retinitis Pigmentosa in Calgary Pde6a Linked Retinitis Pigmentosa in Edmonton Pde6a Linked Retinitis Pigmentosa in Ottawa Pde6a Linked Retinitis Pigmentosa in Winnipeg Pde6a Linked Retinitis Pigmentosa in Quebec City Pde6a Linked Retinitis Pigmentosa in Hamilton Pde6a Linked Retinitis Pigmentosa in Kitchener Pde6a Linked Retinitis Pigmentosa in London Pde6a Linked Retinitis Pigmentosa in Halifax Pde6a Linked Retinitis Pigmentosa in New York Pde6a Linked Retinitis Pigmentosa in Los Angeles Pde6a Linked Retinitis Pigmentosa in Chicago Pde6a Linked Retinitis Pigmentosa in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease